Bank Of New York Mellon Corp Unity Biotechnology, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.3 - $3.17 $18,073 - $44,072	-13,903 Reduced 38.07%	22,620 $33,000
Q3 2021 Nov 12, 2021	BUY	$2.91 - $4.5 $378 - $585	130 Added 0.36%	36,523 $109,000
Q2 2021 Aug 11, 2021	SELL	$4.15 - $6.3 $286,955 - $435,619	-69,146 Reduced 65.52%	36,393 $168,000
Q1 2021 May 13, 2021	SELL	$5.51 - $9.42 $53,171 - $90,903	-9,650 Reduced 8.38%	105,539 $633,000
Q4 2020 Feb 09, 2021	BUY	$3.42 - $6.36 $94,901 - $176,483	27,749 Added 31.73%	115,189 $603,000
Q3 2020 Nov 12, 2020	BUY	$2.94 - $12.43 $1,284 - $5,431	437 Added 0.5%	87,440 $302,000
Q2 2020 Aug 12, 2020	BUY	$5.28 - $9.67 $35,856 - $65,668	6,791 Added 8.47%	87,003 $755,000
Q1 2020 May 06, 2020	BUY	$5.0 - $7.6 $17,250 - $26,220	3,450 Added 4.49%	80,212 $465,000
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $65,943 - $92,255	11,009 Added 16.74%	76,762 $553,000
Q3 2019 Nov 07, 2019	SELL	$5.62 - $9.63 $21,148 - $36,237	-3,763 Reduced 5.41%	65,753 $401,000
Q2 2019 Aug 12, 2019	BUY	$7.59 - $10.21 $46,390 - $62,403	6,112 Added 9.64%	69,516 $660,000
Q1 2019 May 14, 2019	BUY	$7.65 - $16.66 $36,597 - $79,701	4,784 Added 8.16%	63,404 $514,000
Q4 2018 Feb 11, 2019	BUY	$10.76 - $17.25 $461,765 - $740,283	42,915 Added 273.26%	58,620 $953,000
Q3 2018 Nov 09, 2018	BUY	$14.34 - $22.97 $64,988 - $104,100	4,532 Added 40.56%	15,705 $0
Q2 2018 Aug 06, 2018	BUY	$12.76 - $16.94 $142,567 - $189,270	11,173 New	11,173 $168,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.